<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sandu Pharmaceuticals Limited has submitted an annual disclosure to BSE confirming that it does not qualify as a 'Large Corporate' under SEBI's framework. The company is therefore not required to submit the full Annual Disclosure under Annexure B2, which applies only to large entities raising funds through debt securities. The filing includes basic company details (Annexure I format) showing outstanding borrowing as of March 31, 2026, and credit rating information. The company confirmed it meets the criteria for 'Not Large Corporate' status as per SEBI Operational Circulars. This is a routine compliance filing to formally document the non-applicability of certain SEBI disclosure requirements.
No direct impact on shareholders or stock price. This is a procedural filing confirming the company's small-to-mid cap status relative to SEBI's Large Corporate thresholds. It does not indicate any financial distress or change in business operations.